Definium Therapeutics, Inc. (DFTX) — Working Capital to Net Assets Ratio
Definium Therapeutics, Inc. (DFTX) has a Working Capital to Net Assets ratio of 106.1% as of December 2025. Working capital of $352.62 Million (current assets of $419.32 Million minus current liabilities of $66.70 Million) is measured against net assets of $332.33 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Definium Therapeutics, Inc. (DFTX) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Definium Therapeutics, Inc. Working Capital to Net Assets (2015–2025)
This chart shows how Definium Therapeutics, Inc.'s Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 106.1%, reflecting working capital of $352.62 Million against net assets of $332.33 Million USD. See DFTX defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Definium Therapeutics, Inc. (2015–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Definium Therapeutics, Inc. from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Definium Therapeutics, Inc. (DFTX) market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 106.1% | $352.62 Million | $332.33 Million | $419.32 Million | $66.70 Million | ▲ +5.6 pp |
| 2024 | 100.5% | $242.77 Million | $241.45 Million | $281.62 Million | $38.85 Million | ▲ +8.9 pp |
| 2023 | 91.7% | $71.63 Million | $78.13 Million | $103.87 Million | $32.25 Million | ▲ +6.7 pp |
| 2022 | 84.9% | $128.16 Million | $150.92 Million | $146.06 Million | $17.89 Million | ▲ +1.3 pp |
| 2021 | 83.6% | $126.81 Million | $151.66 Million | $137.22 Million | $10.41 Million | ▼ -19.9 pp |
| 2020 | 103.5% | $78.51 Million | $75.87 Million | $81.52 Million | $3.01 Million | ▲ +3.5 pp |
| 2019 | 100.0% | $2.74 Million | $2.74 Million | $2.94 Million | $198.96K | ▲ +94.6 pp |
| 2018 | 5.4% | $190.40K | $3.52 Million | $198.63K | $8.23K | ▼ -37.4 pp |
| 2017 | 42.9% | $1.69 Million | $3.95 Million | $1.77 Million | $80.44K | ▼ -4.9 pp |
| 2016 | 47.7% | $60.72K | $127.28K | $136.19K | $75.47K | ▼ -15.3 pp |
| 2015 | 63.0% | $178.92K | $284.17K | $186.40K | $7.49K | — |